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Background: Gangliosides, sialic acid-containing glycosphingolipids, are highly expressed in nervous systems of
vertebrates and have been considered to be involved in the development, differentiation, and function of nervous
tissues. Recent studies with gene-engineered animals have revealed that they play roles in the maintenance and
repair of nervous tissues. In particular, knockout (KO) mice of various ganglioside synthase genes have exhibited
progressive neurodegeneration with aging. However, neurological disorders and pathological changes in the spinal
cord of these KO mice have not been reported to date. Therefore, we examined neurodegeneration in double
knockout (DKO) mice of ganglioside GM2/GD2 synthase (B4GANLT1) and GD3 synthase (ST8SIA1) genes to clarify
roles of gangliosides in the spinal cord.
Methods: Motor neuron function was examined by gait analysis, and sensory function was analyzed by von
Frey test. Pathological changes were analyzed by staining tissue sections with Klüver-Barrera staining and by
immunohistochemistry with F4/80 and glial fibrillary acidic protein (GFAP). Gene expression profiles were examined
by using DNA micro-array of RNAs from the spinal cord of mice. Triple knockout mice were generated by mating
DKO and complement component 3 (C3)-KO mice. Gene expression of the complement system and cytokines was
examined by reverse transcription-polymerase chain reaction (RT-PCR) as a function of age.
Results: DKO mice showed progressive deterioration with aging. Correspondingly, they exhibited shrunk spinal cord,
reduced thickness of spinal lamina II and III, and reduced neuronal numbers in spinal lamina IX, spinal lamina II, and
spinal lamina I. Complement-related genes were upregulated in DKO spinal cord. Moreover, complement activation
and inflammatory reactions were detected by GFAP-active astrocyte, microglial accumulation, and increased
inflammatory cytokines such as tumor necrosis factor-alpha (TNFα) and interleukin-1-beta (IL-1β). Triple knockout mice
showed restoration of reduced neuron numbers in the spinal cord of DKO mice, getting close to levels of wild-type mice.
Conclusions: Disruption in the architecture of lipid rafts in the spinal cord was not so prominent, suggesting that
mechanisms distinct from those reported might be involved in the complement activation in the spinal cord of DKO
mice. Gene profiling revealed that inflammation and neurodegeneration in the spinal cord of DKO mice are, at least
partly, dependent on complement activation.Background
Gangliosides, sialic acid-containing glycosphingolipids, are
highly expressed in nervous systems of vertebrates [1].
Although gangliosides have been considered to be involved
in the development, differentiation, and function of nervous
tissues, recent studies with gene-engineered animals have* Correspondence: koichi@med.nagoya-u.ac.jp
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repair of nervous tissues [2-4]. Almost all knockout (KO)
mice disrupted of glycosyltransferase genes responsible for
the synthesis of gangliosides exhibited neurodegeneration
in the nervous systems [2]. Although GM2/GD2 synthase
KO mice were reported first to show just subtle neuro-
logical dysfunctions at birth, progressive neurodegenerative
changes were observed with aging [5-7]. GD3 synthase
KO mice also exhibited reduced neuroregeneration of
hypoglossal nerves after injury [8]. Compared with thesetd. This is an Open Access article distributed under the terms of the Creative
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earlier onset and more intense pathological changes were
detected in double KO of GM2/GD2 synthase and GD3
synthase genes (hereafter DKO) [9,10]. Audiogenic seizure
was also observed in these mutant mice [11].
Although lack of all glycosphingolipids generated through
glucosylceramide (GlcCer) resulted in embryonal lethality
[12], conditional KO mice of GlcCer synthase, in which
GlcCer synthase was disrupted in the brain after birth,
also exhibited neurodegeneration [13]. Thus, lack of
gangliosides might cause defects more or less in the
maintenance of integrity of nervous systems, leading to
neurodegeneration. However, neurodegeneration in the
spinal cord caused by the lack of gangliosides have not
been well investigated.
In some neurodegenerative diseases such as Alzheimer’s
disease (AD) and Parkinson’s disease (PD), an important
factor involved in the death of neurons is local inflam-
mation [14], and the classic complement pathway was
actually activated [15,16] in the brain tissues of AD patients.
These results suggest that complement activation and
subsequent inflammation are responsible for the degen-
erative changes in AD brain tissues, although the role of
the complement system in AD is still controversial [17].
In many other neurodegenerative diseases, important
roles of complement systems in the neuroinflammation
and neurodegeneration have been also reported [18].
In this study, we examined abnormal neurological disor-
ders and pathological changes in the spinal cord of DKO
mice to confirm roles of inflammation in the induction
of neurodegeneration in the spinal cord. Based on the
DNA micro-array, we compared gene expression profiles
between DKO and wild-type (WT) mice, and we found
that complement-related genes were upregulated in DKO
spinal cord. Therefore, we investigated whether comple-
ment activation brought about inflammatory reactions
and finally neurodegeneration of the spinal cord in
DKO mice. The DNA micro-array analysis combined
with studies of gene-engineered animals resulted in the
detection of profound findings in the pathogenesis and
mechanisms for the neurodegeneration. Consequently,
genetic approaches revealed that activation of the comple-
ment system is essentially involved in the inflammation
and neurodegeneration in the spinal cord of DKO mice.
Materials and methods
Mice
The generation of KO mice of GM2/GD2 synthase [5] and
GD3 synthase [8] was previously reported. To generate
DKO mice efficiently, we also mated female homozygotes
of the GD3 synthase gene and male heterozygotes of the
GM2/GD2 synthase gene [9]. DKO mice with the two
genes were designated as DKO (or GM3-only) mice, and
wild-type mice for both genes were presented as WTmice. C3-KO mice (B6.129S4-C3tm1Crr/J) were obtained
from The Jackson Laboratory (Bar Harbor, ME, USA).
To generate triple KO (TKO) mice lacking GM2/GD2
synthase, GD3 synthase, and C3, DKO mice of GM2/GD2
synthase and GD3 synthase genes were mated with C3
KO mice, and genotypes of the offspring were screened
for the three genes. Genotypes in C3-KO mice were
screened as described [19]. WT and homozygous mutant
mice of 4, 8, 15, 28 to 32, 42 to 50 weeks, and over
60 weeks after birth were used in this study. All experi-
mental protocols were approved by the animal experi-
mental committee of the Graduate School of Medicine
in Nagoya University in accordance with the guidelines
of Japanese government and were carried out in accord-
ance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals (1966). The number
of animals used and their suffering were minimized.
Antibodies
Antibodies used for Western immunoblotting were as
follows: monoclonal anti-mouse C1q (rat IgG1) (Hycult
Biotech, Uden, The Netherlands), monoclonal anti-β-actin
(mouse IgG) (Sigma-Aldrich, St. Louis, MO, USA), or
monoclonal anti-porcine glial fibrillary acidic protein
(GFAP) (mouse IgG1) (Chemicon, Temecula, CA, USA).
Chemiluminescence detection was performed by using
horseradish peroxidase (HRP)-conjugated rabbit anti-rat
IgG (H + L) (Zymed Laboratories, now part of Invitrogen,
Carlsbad, CA, USA) and sheep anti-mouse IgG (Amersham
Biosciences, now part of GE Healthcare, Little Chalfont,
Buckinghamshire, UK). Antibodies used for immunohisto-
chemistry were as follows: monoclonal anti-porcine GFAP
(mouse IgG1) (Chemicon) and monoclonal anti-mouse F4/
80 (rat IgG2b) (Serotec, Oxford, UK). Immunofluorescence
detection was performed by using Alexa Fluor 488-goat
anti-rat IgG2b (Invitrogen) or Alexa Fluor 555-goat anti-
mouse IgG1 (Invitrogen).
Primers
Primers used for real-time reverse transcription-polymerase
chain reaction (RT-PCR) were designed according to
Primer 3 Input™ [20] as shown in Additional file 1:
Table S1.Extraction of glycolipids and thin-layer chromatography
Glycolipid extraction and thin-layer chromatography (TLC)
were performed as described previously [21]. Briefly, lipids
were extracted by chloroform/methanol at ratios of 2:1, 1:1,
and then 1:2 sequentially. Glycolipids were isolated by
a Florisil column after acetylation, and then neutral and
acidic fractions were separated by DEAE-Sephadex (A-50)
column chromatography.
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The footprint test is performed by applying Chromacryl
(Chroma Acrylics, Lititz, PA, USA) to mouse feet.
Usually, a red color is used on the forelimb and a blue
color for the hind limb. Mice were then placed within
a restricted cardboard tunnel (80 cm long × 10 cm
wide × 10 cm high) with a white paper-covered floor,
and footprints were made while the animal walked.
von Frey test
Response to mechanical stimuli was examined by the
von Frey test. To determine the paw withdrawal thresh-
old to mechanical stimulation, the plantar surface of the
hind paws in the WT and DKO mice was stimulated
with a set of calibrated nylon monofilaments (von Frey
hairs) with increasing force until the mice withdrew
the limb. The minimum intensity of mechanical stimuli
was taken as the force at which the mouse withdrew
the paw.
Klüver-Barrera staining
WT and DKO mice were perfused with phosphate-
buffered saline (PBS) and then with 10% neutral buffered
formalin (Wako, Osaka, Japan). Then the spinal cord
was removed and was post-fixed with 10% neutral buff-
ered formalin followed by Klüver-Barrera (KB) staining.
The spinal cord was cut into lumber spinal cord segments
L3-L4 and embedded in paraffin after dehydration and
paraffin penetration. Blocked spinal cord was cut into
5 μm of cross-sections, and slices of spinal cord were
stained with luxol fast blue solution and cresyl violet
solution (KB staining). KB-stained slices of the spinal
cord were observed by light microscopy.
DNA microarray
The spinal cords isolated from 28- and 48-week-old mice
(n = 3) were homogenized in Trizol™ (Invitrogen), and
total RNA was extracted from tissues in accordance
with the protocol of the manufacturer (Invitrogen). The
quantity and purity of RNAs were checked by determining
absorbance at 260/280 nm by using a spectrophotometer.
Briefly, total RNA was reverse-transcribed to complemen-
tary DNA (cDNA) with T7-oligo (dT) primer (Affymetrix,
Santa Clara, CA, USA). The cDNA synthesis product was
used in an in vitro transcription reaction by using T7 RNA
polymerase and biotinylated nucleotide analog (pseudo-
uridine base). Then the labeled cRNA products were
fragmented and loaded onto a CodeLink Uniset Mouse
20 K I Bioarray™ (Affymetrix) and hybridized in accordance
with the protocol of the manufacturer. Streptavidin-
phycoerythrin (Molecular Probes, now part of Invitrogen)
was used as the fluorescent conjugate to detect hybridized
target sequences. Signal intensity data from the GeneChip
array were analyzed by GeneChip Operating Software(Affymetrix). Signal intensities for each spot were calcu-
lated by summation of the pixel intensities for each spot,
and then the local background (based on the median
pixel intensity of the area surrounding each spot) was
subtracted. Array data normalization was performed
independently for each slide by dividing each spot’s in-
tensity (after background subtraction) by the median
signal intensity of probes.
Real-time reverse transcription-polymerase chain reaction
WT and DKO mice were perfused with PBS. The spinal
cords were isolated from mice and homogenized in
Trizol™. Total RNA was extracted from tissues by Trizol™
in accordance with the protocol of the manufacturer. After
the quantity and purity of RNAs were checked by deter-
mining absorbance at 260/280 nm by using a spectropho-
tometer, total RNA was reverse-transcribed into cDNA
by using M-MLV Reverse Transcriptase™ (Invitrogen)
and oligo dT primer (Sigma-Aldrich). cDNA was frozen
at −80°C until use.
Real-time RT-PCR was performed by using 4 ng cDNA
per well, with F-400 or F-410 in a SYBR green qPCR kit™
(Finnzymes, Espoo, Finland) and a Thermal Cycler PTC-
200™ (MJ Research, now part of Bio-Rad Laboratories,
Inc., Hercules, CA, USA). The PCR conditions were as
follows: preheating at 95°C for 10 minutes, 40 cycles of
95°C (10 seconds), 60°C (20 seconds), and 72°C (20 seconds).
The plate reader was set at 78°C or 75°C (2 seconds)
depending on individual primer pairs. For the internal
control in the quantitative analysis, mGAPDH was used.
Every sample was measured in duplicate, and the gene
expression levels were analyzed by using Opticon Moni-
ter3™ software (Bio-Rad Laboratories, Inc.).
Western immunoblotting
The spinal cords were isolated after perfusion with PBS
from mice and were homogenized in lysis buffer (10 mM
Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 5 mM MgCl2, 50 mM NaF, 1 mM NaVO4, 1% Tri-
ton X-100, 200 mM PMSF, 0.01-0.02 TIU/mL aprotinin).
The lysates were pelleted by centrifugation at 8,000 g for
60 minutes at 4°C. The supernatant was centrifuged at
18,000 g for 90 minutes at 4°C, and clarified lysates were
used for immunoblotting. Lysates were frozen at −80°C
until use.
Lysates from the spinal cord of WT and DKO mice
were mixed with SDS sample buffer, heated at 100°C for
5 minutes, and resolved by a 10% to approximately 12%
SDS-PAGE. Proteins were transferred onto polyvinyli-
dene difluoride membranes by semi-dry electrophoresis
for 60 minutes at 15 V. Membranes were incubated in
PBST (PBS containing 0.1% Tween 20) with 5% skim
milk for 2 hours at room temperature or overnight at
4°C, then incubated with primary antibodies for 1 hour
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conjugated second antibodies for 45 minutes at room
temperature. Bands were visualized by ECL™ (Western
Lightning Chemiluminescence Reagent; PerkinElmer Life
Sciences, Waltham, MA, USA).Immunohistostaining
WT and DKO mice were perfused with PBS and then 4%
paraformaldehyde in 0.1 M phosphate buffer. The spinal
cord was removed, post-fixed with 4% paraformaldehyde
in 0.1 M phosphate buffer overnight at 4°C, then replaced
with 10% sucrose for 6 hours, 15% sucrose for 6 hours,
20% sucrose for 6 hours, and embedded in OCT com-
pound (Sakura Finetechnical, Nagoya, Japan) and frozen
in liquid nitrogen. Frozen sections were set at longitudinal
orientation for the spinal cord and were cut into 7 μm-
thick sections on a cryostat (CM3050S; Leica, Wetzlar,
Germany) at −20°C. The sections were placed on MAS-
coat grids (Matsunami Glass, Osaka, Japan), and tissue
slices were stored at −80°C until used.
For immunohistochemistry, tissue slices were washed
twice with PBS for 5 minutes at room temperature, blocked
with 10% normal goat serum for 1 hour at room temp-
erature, and incubated with primary antibodies for 1 hour
at room temperature or overnight at 4°C. Then slices
were washed 3 times with PBS for 5 minutes at room
temperature, and incubated with Alexa Fluor-conjugated
second antibodies for 45 minutes at room temperature.
Then they were washed 3 times with PBS for 5 minutes at
room temperature, and were sealed with PermaFlour™
aqueous mounting medium (Thermo Fisher Scientific
Inc., Waltham, MA, USA). Cover slips were mounted
and observed by fluorescence microscopy.Enzyme-linked immunosorbent assay
After perfusion with PBS, the spinal cords were isolated
from mice and homogenized and sonicated in lysis buffer
(10 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 5 mM MgCl2, 50 mM NaF, 1 mM NaVO4,
1% Triton X-100, 1 mM PMSF, 0.01-0.02 TIU/mL aproti-
nin) (spinal cord 100 mg tissue/300 μL lysis buffer).
The lysates were centrifuged at 8,000 g for 60 minutes at
4°C, and the supernatants were centrifuged at 18,000 g for
90 minutes at 4°C. Five hundred μg/50 μL of tissue lysates
was used for the assay. Levels of interleukin-1-alpha
(IL-1α), IL-1β, and tumor necrosis factor-alpha (TNFα)
proteins were determined by using assay kits for mouse
IL-1α/IL1F1™, mouse IL-1β/IL-1 F2™ enzyme-linked im-
munosorbent assay (ELISA), or mouse TNFα/TNFF1A™
(R&D Systems, Minneapolis, MN, USA). The assay was
performed in accordance with the instructions of the
manufacturer.Statistical analysis
All results were presented as the mean ± standard devi-
ation and were initially subjected to the Bartlett, Hartley,
and Levene test for homogeneity of variance. The Shapiro-
Wilk test was used to verify that the data followed a normal
distribution. Statistical significance was calculated by using
Student t test in cases of two comparison groups and
one-way analysis of variance (ANOVA) followed by Tukey-
Kramer post hoc test in cases of more than two comparison
groups. Two-way ANOVA followed by Bonferroni post hoc
test was used comparing mouse group and time course.
All statistical significances were set at *P <0.05, **P <0.01,
***P <0.001.
Results
Abnormal phenotypes of mice by deletion of GM2/GD2
synthase and GD3 synthase
We generated DKO mice lacking the GM2/GD2 synthase
and the GD3 synthase genes (Figure 1A) and investigated
phenotypes of the DKO mice. Ganglioside composition in
the spinal cord as analyzed by TLC exhibited only GM3 in
DKO mice (Figure 1B). In the footprint test, DKO mice
walked in a zigzag line (Figure 1C) and with abnormal
stride (Figure 1D) whereas WT mice showed straight
walking. These abnormal gates were exacerbated with
aging in DKO mice (Figure 1D). Interaction of mouse
group and time course did not turn out to be statistically
significant (P = 0.2624). The differences among time
courses in DKO mice (but not WT mice) turned out to be
statistically significant (WT, P = 0.674; DKO, P = 0.0167)
(Figure 1D). Sensory nerve functions in the 7-, 14-, 25-,
32-, and 42-week-old mice were examined with the von
Frey test. Sensitivity to mechanical pain stimuli in the hind
limbs apparently reduced at 25 weeks after birth or later
(Figure 1E). Interaction of mouse groups and time courses
showed P = 0.0311. The results of comparison among
time courses in mice were as follows: WT, P = 0.00226;
DKO, P = 0.00173 (Figure 1E). These results suggested
that abnormal nerve functions occurred because of the
lack of gangliosides in DKO mice. Furthermore, the spinal
cords of 44-week-old DKO mice were thinner than those
in WT mice (Figure 1F) and weighed less in the DKO
mice both at 30 weeks (WT: 120.6 ± 7.8 mg, n = 11 versus
DKO: 112.6 ± 4.9 mg, n = 10) and at 50 to 65 weeks
after birth (WT: 143.6. ± 10.5 mg, n = 13 versus DKO:
120.0 ± 10.1 mg, n = 12) (Figure 1G).
Neurodegeneration of the spinal cord in double
knockout mice
To examine whether histopathological changes related to
abnormal gait and reduced sensitivity to mechanical pain
stimuli occur in the spinal cord of DKO mice, we per-
formed KB staining for lumber spinal cord 3 (L3) of spinal
cord from 44-week-old WT and DKO mice (Figure 2A).
Figure 1 Abnormal phenotype in double knockout (DKO) mice. (A) A synthetic pathway of gangliosides. Structures boxed in two squares
were depleted in DKO mice. (B) Thin-layer chromatography (TLC) of gangliosides from spinal cord of 15-week-old wild-type (WT) and DKO mice
was performed with control gangliosides from bovine brain (lane M). Resorcinol was used for the detection. (C) Gait pattern was examined by the
footprint test in 70- to 80-week-old mice. A red color was used for the forelimb and a blue color for the hind limb. (D) Average values for stride length
of hind limb in individual age WT and DKO mice. The number of tissues examined was n = 3 or 4 (WT, open circles; DKO, closed circles). Data
were analyzed by two-way analysis of variance (ANOVA). Comparison of WT and DKO with same age revealed that they were statistically significant
by Bonferroni post hoc test (shown in figure, *P <0.05; **P <0.01). (E) von Frey strings test in individual age WT and DKO mice. The number of tissues
examined was n = 3 or 4 (WT, open circles; DKO, closed circles). Two-way ANOVA analysis of data was performed as described in (D). Comparison of
WT and DKO with same age was done, and the results are shown (*P <0.05; **P <0.01). (F) Photographs of fixed spinal cord from 44-week-old WT and
DKO mice. Scale: centimeter (cm). (G) Weights of the spinal cord of WT and DKO mice. The numbers of tissues examined were n = 11~13 (WT, open
columns; DKO, closed columns). Data were presented as mean ± standard deviation (SD) and were analyzed by Student t test (*P <0.05; ***P <0.001).
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Figure 2 Neurodegeneration in the spinal cord of double knockout (DKO) mice. (A) Spinal cord sections of 44-week-old mice were stained
with Klüver-Barrera (KB). Enlarged images indicated spinal lamina XI (motor neuronal region) in the spinal cord as shown by square. (B) The
numbers of motor neuron in the spinal lamina XI of lumber spinal cord segments L3 were counted and presented as the number of motor
neurons. (C) An enlarged anterior horn—spinal lamina I, II, and III indicated by dashed squares in (A)—of spinal cord sections stained with KB.
(D) Thicknesses of spinal lamina II and III were measured in lumber spinal cord segments L3 in wild-type (WT) and DKO mice and presented
as the thicknesses of spinal lamina II and III. (E) The numbers of spinal lamina II neurons and marginal cells in spinal lamina I were counted
and presented as the number of neurons. The numbers of mice examined are as follows: 44-week-old WT (n = 4; open columns) and DKO
(n = 4; closed columns); data are presented as mean ± standard deviation (SD) and were analyzed by Student t test (*P <0.05; **P <0.01;
***P <0.001). The thickness of sections was 5 μm.
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mice as shown in spinal lamina IX (Figure 2A and B). The
thickness of spinal lamina II and III decreased in DKO
mice compared with WT mice (Figure 2C and 2D). The
number of neuronal cells in spinal lamina II and that of
marginal cells (in spinal lamina I) also decreased in DKO
mice compared with WT mice (Figure 2D). These results
suggested that abnormal phenotypes found in gait and
sensitivity to mechanical pain stimuli were caused by
neurodegeneration in the spinal cord of DKO mice.Genes of complement components were upregulated in
the spinal cords of double knockout mice
To investigate the mechanisms by which neurodegenera-
tion was caused in DKO mice, we performed a DNA
microarray analysis with mRNAs from the spinal cords
of 28- and 48-week-old mice. Among genes differentially
expressed between WT and DKO mice, complement
genes (C1qα, C4, and C3aR) were found to be generally
upregulated in the spinal cord (Table 1). The expression
level of C4 was markedly upregulated in both the 28-
Table 1 Relative expression levels of complement
components in the spinal cord using DNA microarray
Weeks Gene WT (expression) DKO (expression) Ratio
C1qα 9.84 15.79 1.60
28 weeks C4 4.07 10.27 2.53
C3aR 0.34 0.51 1.52
C1qα 11.17 24.14 2.16
48 weeks C4 6.71 14.09 2.10
C3aR 0.29 1.44 5.04
Expression levels of genes in wild-type (WT) and double knockout (DKO) mice
were quantified based on normalized signal intensities (see Materials and
methods) obtained from DNA microarray.
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DKO: 10.27 and 48-week-old WT: 6.71.07 versus DKO:
14.09). The expression level of C3aR, receptor for ana-
phylatoxin C3a, was most strongly upregulated in the
48-week-old DKO mice (WT: 0.29 versus DKO: 1.44).
To precisely determine the gene expression profiles, we
performed real-time reverse transcription-PCR (RT-PCR)
with mRNAs from individual mice. Consequently, the
expression level of C4 was upregulated in DKO mice
compared with WTat all ages examined (Additional file 1:
Figure S1A). The expression level of C3aR was upregu-
lated in all DKO male mice and many DKO female mice
(Additional file 1: Figure S1B). These results indicated that
C4 and C3aR were upregulated regardless of the presence
of skin injury and more definitely in male DKO mice than
in female. Since complement system functions in innate
immunity and inflammatory reactions with sequential
activation of diverse components, we performed real-time
RT-PCR for complement system-related genes by using
mRNAs from the spinal cord and liver of 28-week-old
mice. The expression levels of C1qα, C4, C5, C3aR, and
C5aR were significantly upregulated in the spinal cord of
DKO mice (Figure 3A). The expression levels of C1qβ,
C1qγ, and C3 in the spinal cord tended to increase in the
DKO mice. The expression of C6, C7, C8β, and C9 could
not be detected. These results suggested that the majority
of complement-related genes were upregulated in the
spinal cord of DKO mice. On the other hand, the
expression levels of complement-related genes were
generally higher in the liver than in the spinal cord,
and C4 was persistently low in the liver of DKO mice
compared with WT mice (Figure 3B). Thus, the expres-
sion of these genes in the central nervous system (CNS)
seemed to be regulated in a distinct manner from that in
the liver (Additional file 1: Figure S2).
Complement components were chronologically
upregulated in the spinal cord of double knockout mice
Because the phenotypes of the DKO mice were exacer-
bated with aging, we performed real-time RT-PCR to
examine chronological changes in the expression levelsof C1qα, C3, C4, C3aR, and C5aR by using mRNAs from
the spinal cord of 4-, 15-, 28-, and 48-week-old WT and
DKO mice (Figure 4A). All of these genes showed no or
minimal differences at 4 weeks after birth between WT
and DKO mice. The expression levels of complement genes
were then upregulated in DKO mice with aging. These
results suggested that upregulation of complement genes
took place along with neurodegeneration in the ner-
vous tissues of DKO mice. Furthermore, we performed
immunoblotting to investigate the protein levels of C1q
in the spinal cord of the DKO mice. Since C1q proteins
are essential in the complement system, we examined
the C1q protein in the spinal cord of 15-week-old mice,
showing equivalent levels between WT and DKO mice.
But it increased 2.3-fold in 30-week-old DKO mice and
just tended to be higher in 60-week-old DKO mice
(Figure 4B), whereas its mRNAs were upregulated with
aging. There results suggested that complement com-
ponents were consumed with complement activation.
Abnormal proliferation of astrocytes and accumulation of
microglia in the spinal cord of double knockout mice
To investigate whether inflammation occurs in the spinal
cord of DKO mice, we performed immunohistostaining
of astrocytes (GFAP) and microglia (F4/80). We found
no definite difference in GFAP staining of white matter
between WT and DKO mice at 8 to about 60 weeks
after birth (Figure 5A). On the other hand, GFAP-active
astrocytes in gray matter was found more prominently in
8-, 15-, and 30-week-old DKO mice than in WT mice
(Figure 5B), whereas no difference was found between
WT and DKO mice in 60-week-old mice. The increased
GFAP expression in DKO mice with aging was confirmed
by immunoblotting (Figure 5C-E). GFAP bands increased
at 15 to about 30 weeks after birth in DKO mice com-
pared with WT mice but were almost equivalent at
60 weeks after birth between WT and DKO mice. Accu-
mulation of microglia tended to increase at 30 weeks after
birth and significantly accumulated hereafter, whereas no
difference could be found at 8 to approximately 15 weeks
after birth between DKO and WT mice (Figure 5F and G).
Secretion of inflammatory cytokines in the spinal cord of
double knockout mice
To investigate whether abnormal proliferation of astro-
cytes and accumulation of microglia are associated with
actual inflammation, we measured mRNA expression levels
of inflammatory cytokines (IL-1α, IL-1β, and TNFα) in the
spinal cord of WT and DKO mice with real-time RT-PCR.
Expression levels of IL-1α and IL-1β were significantly
upregulated in 4- and 15-week-old DKO mice, and those
of IL-1α and TNFα were significantly upregulated in
48-week-old DKO mice (Figure 6A). Expression levels
of IL-6 and INFγ could not be detected in either type of
Figure 3 Expression levels of complement components were upregulated in the spinal cord and liver of wild-type (WT) and double
knockout (DKO) mice. mRNA levels of complement genes (C1qα, C1qβ, C1qγ, C2, C3, C4, C5, C6, C7, C8α, C8β, C8γ, C9, C3aR, and C5aR) in the spinal
cord (A) and liver (B) of WT and DKO mice were analyzed by real-time reverse transcription-polymerase chain reaction (RT-PCR) and presented after
correction with the mouse GAPDH gene. The numbers of mice examined were as follows: 28-week-old male WT (n = 3; open columns) and DKO (n = 3;
closed columns); data were presented as mean ± standard deviation (SD) and were analyzed by Student t test (*P <0.05; **P <0.01). ND, not detected.
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cytokines. None of these inflammatory cytokines was
detected at 30 weeks after birth, but they tended toincrease at 60 weeks (Figure 6B). These results suggested
that the spinal cord of DKO mice underwent inflamma-
tory reaction, and it was exacerbated with aging.
Figure 4 Complements were upregulated with aging in the spinal cord of double knockout (DKO) mice. (A) mRNAs from spinal cord of
4-, 15-, 28-, and 48-week-old wild-type (WT) and DKO mice were analyzed for the expression levels of complement genes with real-time reverse
transcription-polymerase chain reaction (RT-PCR) and presented after correction by mouse GAPDH gene (gray diamond, WT; closed circle, DKO).
The numbers of mice examined were as follows: 4-, 15-, 28-, and 48-week-old WT (n = 3) and DKO (n = 3); data are presented as mean ± standard
deviation (SD), and analysis of data by two-way analysis of variance (ANOVA) was performed as described in Figure 1D. Interaction of mouse groups
and time courses: C1qα, C3, and C4, P <0.01; C3aR and C5aR, P <0.05. The comparison among time courses in mice revealed that all genes in WT and
DKO mice, except for C4 in WT mice, turned out to be statistically significant. Comparison of WT and DKO with same age is shown in figure (*P <0.05;
**P <0.01) (B) Western immunoblotting of C1q in the spinal cord was performed by using total lysates from 15-, 30-, and 60-week-old WT and DKO
mice. The intensity of the bands was corrected with that of β-actin and presented as mean ± SD. The numbers of mice examined were as follows:
15-week-old WT (n = 2), DKO (n = 2); 30-week-old WT (n = 3), DKO (n = 3); 60-week-old WT (n = 2), DKO (n = 3); data are presented as mean ± SD and
were analyzed by Student t test (*P <0.05; **P <0.01).
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spinal cord of double knockout mice by deletion of
complement C3
To investigate whether the inflammatory reaction and
neurodegeneration in DKO mice are due to complement
activation and can be rescued by disruption of comple-
ment systems, we generated TKO mice by mating the
DKO mice of GM2/GD2 synthase and GD3 synthase genes
with C3 KO mice (Figure 7A). As expected, expression
levels of C3 were null in the TKO mice (Figure 7B), and
C1qα in TKO also reduced to levels almost equivalent to
that in WT mice. By measuring mRNA expression levelsof inflammatory cytokines (IL-1β and TNFα), expression
of TNFα was downregulated in the TKO mice, whereas
IL-1β tended to decrease when compared with that in DKO
mice (Figure 7B). As for F4/80 immunohistostaining, accu-
mulation of microglia completely became equivalent
between TKO and WT mice (Figure 7C). These results
indicated that inflammatory reactions observed in DKO
mice almost subsided in TKO mice.
To clarify whether the neurodegeneration of the spinal
cord in DKO mice could be restored by disruption of
complement systems, L3 of the spinal cord in 44- to 50-
week-old mice was stained by KB staining. As described
Figure 5 (See legend on next page.)
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Figure 5 Immunohistostaining of the spinal cord for glial fibrillary acidic protein (GFAP) and F4/80. (A, B) Immunohistostaining of GFAP
in the spinal cord of 8-, 15-, 30-, and 60-week-old wild-type (WT) and double knockout (DKO) mice. GFAP (astrocyte marker) was detected with
monoclonal anti-GFAP and Alexa Fluor 555-conjugated anti-mouse IgG1. Staining patterns of GFAP showed no difference in the white matter
between WT and DKO mice at all stages examined. In the gray matter, GFAP staining in 8- and 15-week-old DKO mice increased. Eventually, there was no
difference between the WT and DKO mice at 30 and 60 weeks. (C-E)Western immunoblotting of the spinal cord lysates from 15-, 30-, and 60-week-old
WT and DKO mice. GFAP increased in the 15-week-old DKO mice compared with WT mice, but the difference in GFAP protein levels between WT and
DKO mice reduced with aging. Beta-actin levels were also analyzed to confirm equal sample loading. The numbers of mice examined were as follows:
15-week-old WT (n = 2), DKO (n = 2); 30-week-old WT (n = 3), DKO (n = 3); 60-week-old WT (n = 2), DKO (n = 3); data are presented as mean ± standard
deviation (SD). (F) Immunohistostaining of F4/80 (microglia marker) in the spinal cord of 8-, 15-, 30-, and 60-week-old WT and DKO mice by
using monoclonal anti-mouse F4/80 and Alexa Fluor 488-conjugated anti-rat IgG2b. (G) The number of microglia was quantified as an average
in the visual field of the fluorescence microscope (×400). Microglia numbers significantly increased in 60-week-old DKO mice compared with
the WT mice. The numbers of mice examined were as follows: 4-, 15-, and 30-week-old WT (n = 2), DKO (n = 2), 60-week-old WT (n = 3), DKO
(n = 3); data are presented as mean ± SD. Thickness of sections was 10 μm (scale bar, 50 μm). Data were analyzed by Student t test (*P <0.05).
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mice compared with WT mice. The number of motor
neurons (spinal lamina IX cells) and neuronal cells in
the spinal lamina II was fairly restored in TKO mice, but
thicknesses of spinal lamina II + III and marginal cells
(in spinal lamina I) were almost equivalent between
DKO and TKO mice (Figure 8A and B). These results
suggested that the inflammatory reaction and neurode-
generation observed in DKO mice were definitely alleviatedFigure 6 Inflammatory cytokine levels increased in the spinal cord of
spinal cord of individual mice were analyzed for the expression levels of cytok
(RT-PCR) and corrected by the mouse GAPDH gene. Compared with wild-
and tumor necrosis factor-alpha (TNFα) in the spinal cord of the DKO mice we
mice examined were as follows: 4-, 15-, 28-, and 48-week-old WT (n = 3) and D
performed as described in Figure 1D. For interaction of mouse groups and tim
among time courses in mice, only TNFα in DKO mice turned out to be st
same age is shown in figure (*P <0.05; **P <0.01). (B) Protein levels of IL-1α, IL
mice were analyzed with enzyme-linked immunosorbent assay (ELISA). The nu
(n = 3) and DKO (n = 3); data are presented as mean ± standard deviation (SDin the TKO mice. However, neurodegeneration in the spinal
cord could not be completely restored in the TKO mice
compared with the WT mice.
Discussion
Aberrant expression of gangliosides have been reported
in a variety of neurological disorders and their animal
models (for example, in the spinal cord of amyotrophic
lateral sclerosis (ALS) [22], brain tissues of patients withdouble knockout (DKO) mice with aging. (A) mRNAs from the
ine genes with real-time reverse transcription-polymerase chain reaction
type (WT) mice, expression levels of interleukin-1-alpha (IL-1α), IL-1β,
re upregulated with aging (diamond, WT; circle, DKO). The numbers of
KO (n = 3). Analysis of data by two-way analysis of variance (ANOVA) was
e courses, all genes were not statistically significant. In the comparison
atistically significant (P = 0.0424). Comparison of WT and DKO with
-1β, and TNFα in the spinal cord of 30- and 60-week-old WT and DKO
mbers of mice examined were as follows: 30- and 60-week-old WT
) and were analyzed by Student t test (*P <0.05). ND, not detectable.
Figure 7 Alleviation of the complement activation, inflammation, and neurodegeneration in double knockout (DKO) mice by
disruption of complement C3 gene. (A) To clarify the involvement of complement systems in the inflammatory reactions and
neurodegenerations in DKO mice, DKO- and C3-deficient mutant mice were mated, generating triple knockout (TKO) mice. (B) Expression levels
of complement mRNAs from the cerebellum of 40-week-old mice were analyzed for C1qα, C3, IL-1β, and TNFα genes with real-time reverse
transcription-polymerase chain reaction (RT-PCR). Relative expression levels are presented after correction by the GAPDH gene. The numbers of
mice examined were as follows: wild-type (WT) (n = 5), DKO (n = 5), TKO (n = 5), and C3KO (n = 3); data are presented as mean ± standard devi-
ation (SD) and were analyzed by one-way analysis of variance (ANOVA) with Tukey-Kramer post hoc test (*P <0.05; **P <0.01; ***P <0.001). (C)
Immunohistostaining of F4/80 (microglia marker) in the spinal cord of 40-week-old WT and DKO mice by using monoclonal anti-mouse F4/80
and Alexa Fluor 488-conjugated anti-rat IgG2b. The number of microglia was quantified as an average in a visual field of the fluorescence micro-
scope (×400). Numbers of section area examined were as follows: WT (n = 3), DKO (n = 3), TKO (n = 3), and C3KO (n = 3); data are presented as
mean ± SD and were analyzed by one-way ANOVA with Tukey-Kramer post hoc test (**P <0.01; ***P <0.001). The thickness of sections was 7 μm
(scale bar, 50 μm).
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results suggested that ganglioside administration might
bring about beneficial effects in these diseases. In particu-
lar, GM1 was reported to be effective for the treatment of
PD in primates [25], and randomized controlled studies
for patients with PD have been tried, showing that it is safe
and may provide some clinical benefit to the patients [26].
GM1 has been also used for the treatment of spinal cord
injury [27]. These results suggested that gangliosides are
deeply involved in the maintenance of the integrity of
nerve tissues, and supplement of them may be a choice as
therapeutic agents for the neurodegenerative diseases.
In this study, the relationship between neurological
disorders and pathological damages in the spinal cord ofDKO mice was examined. Motor neuron deficits as shown
in abnormal gait and sensory nerve disorders as demon-
strated in elevated threshold to the pain stimulation of
von Frey test deteriorated with aging. Correspondingly
with these behavioral abnormalities, sizes in the spinal
cord and spaces of individual compartments such as
dorsal horn and ventral horn shrank as shown in Figure 2.
All of these findings suggested that complex gangliosides
are essential for the maintenance of the integrity of the
spinal cord as shown in various knockout mice of ganglio-
side synthase genes [2,3,28].
As for human diseases that are modeled by ganglioside-
deficient mice, “infantile-onset symptomatic epilepsy syn-
drome” can be raised [29]. The responsible gene for this
Figure 8 Restoration of reduced neuron numbers in double knockout (DKO) mice by disruption of complement C3 gene. (A) Spinal
cord sections of 44- to 50-week-old mice stained with Klüver-Barrera (KB). Enlarged images indicated XI layer (motor neuronal region) in the spinal
cord. (B) The numbers of motor neurons were counted in the spinal lamina XI of lumber spinal cord segments L3 and presented as the number
of motor neurons. The thickness of sections was 5 μm (scale bar, 100 μm). The thickness of spinal lamina II + III was measured in lumber spinal
cord segments L3 in wild-type (WT) and DKO mice and presented as the thickness of spinal lamina II + III. The numbers of spinal lamina II neurons
and marginal cells in spinal lamina I were counted and presented as the number of neurons. The numbers of mice examined were as follows:
44- to 50-week-old WT (n = 4), DKO (n = 4), triple knockout (TKO) (n = 5), and C3KO (n = 3); data are presented as mean ± standard deviation (SD)
and were analyzed by one-way analysis of variance (ANOVA) with Tukey-Kramer post hoc test (*P <0.05; **P <0.01; ***P <0.001).
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seven cases of “complex hereditary spastic paraplegia”
with GM2/GD2 synthase mutations (eight mutations)
were reported [30]. In these cases, similar abnormal
features with our KO mice could be seen, suggesting use-
fulness of the KO mice for the analysis of these diseases.
The gene expression profiling using RNA from the spinal
cord of 28- and 48-week-old WT and DKO mice revealed
that complement systems in DKO were generally activated.
Not only main components of the complement system but
also their receptor genes were also upregulated, suggesting
increased consumption of them. Recently, involvement of
inflammation and immune systems in the neurodegenera-
tion has been increasingly recognized [31], and roles of
complement systems in the physiological and pathological
processes in CNS have been extensively studied [18,32,33].
Although the majority of components in the complement
system are expressed in the brain tissues [32,34], no studies
on complements in the spinal cord have been reported
so far.
In various neurodegenerative diseases such as AD, an
important factor involved in the death of neurons is local
inflammation [14,35]. All components involved in the
classic complement pathway could be found in neurons
and glial cells [34], and this pathway was activated as
shown in fibrillar β-amyloid [15] or neurofibrillary tangles
[16] in the brain tissues of patients with AD. These results
strongly suggested that complement activation and
subsequent inflammation are responsible factors for the
degenerative changes in AD brain tissues but that the
role of the complement system in AD pathogenesis and
progression is complex [17]. Indeed, absence of C1q
leads to less neuropathology in mouse models of AD[36]. Furthermore, treatment with a C5aR antagonist de-
creases pathology and enhances behavioral performance in
AD model mice [37]. In many neurodegenerative diseases
other than AD, including traumatic damages, important
roles of complement systems in the neuroinflammation
and neurodegeneration have been also reported [18].
In ALS, complement is significantly involved in the
disease model [38] and its inhibitor might be beneficial
for the treatment of ALS [39].
As expected, TKO mice generated by mating DKO mice
of two ganglioside synthases and C3 gene KO mice showed
apparent improvement in the inflammatory reaction, mic-
rogliosis, and neurodegeneration as shown in the sizes and
neuron numbers in the spinal cord. Although the restor-
ation of these degenerative features was not complete (that
is, not equivalent to that of WT mice), they showed signifi-
cant improvement, suggesting that inflammatory reaction
via complement activation should be a main mechanism
for the neurodegeneration due to ganglioside deficiency.
How complement systems are activated by the lack of
gangliosides is not known at this time. Recently, innate
immune responses within CNS have been widely recog-
nized as playing a major role in the development of auto-
immune disorders and neurodegeneration such as multiple
sclerosis and AD [40]. Among neuro-immune regulatory
proteins (NIReg), GPI-anchored proteins, molecules
of the immunoglobulin superfamily (like siglecs), and
complement C3a and factor H are included. In particular,
complement regulatory factors such as H and I were re-
ported to bind to gangliosides, resulting in the inactivation
of alternative pathway of complement [41]. They demon-
strated the ability of sialic acid on glycolipids to promote
factor H binding to C3b, resulting in the suppression of
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that sialic acid on a microbial surface bound defined
site of factor H, resulting in the increased conversion of
bound C3b to iC3b [42]. This might be a mechanism
for serum resistance of Neisseria gonorrhoae. In these cases,
inhibitory effects of gangliosides were dose-dependent
and not specific for the site of sialic acid substitution in
gangliosides [41].
In addition, patients with hemolytic uremic syndrome
due to factor H mutation were actually reported [43,44].
These results suggest that complement activation in
DKO mice might come, at least partly, from insufficient
inhibition of complement activation with factor H due
to loss of gangliosides. Correspondingly, erythrocytes from
DKO mice lacking complex gangliosides showed increased
sensitivity to complement (rabbit)-dependent hemolysis
(unpublished data). On the other hand, a report also
indicates that gangliosides activate complement system
by using an in vitro system [45].
In turn, gangliosides have been reported to play roles in
the regulation of functions and architecture of membrane
microdomains in the neural tissues [28,46]. In our study
of cerebellum in DKO mice, disrupted lipid rafts were
demonstrated [47,48]. However, fractionation of mem-
brane extracts with Triton X-100 revealed that the distri-
bution of raft markers was not so disturbed in the spinal
cord of DKO mice. Therefore, the mechanisms for the
neurodegeneration due to ganglioside deficiency might
not necessarily be the same between cerebellum and
spinal cord.
As shown above, even TKO mice did not achieve
complete restoration of abnormal findings indicating
inflammation and neurodegeneration. In particular, astro-
cytosis in the nerve tissues did not decrease by the genetic
deletion of C3, suggesting not only activation of the
complement system but involvement of some other fac-
tors in the inflammatory reaction in the spinal cord of
DKO mice. Among them, disturbed regulation of various
membrane molecules on neurons and glial cells due to
ganglioside deficiency should be included. In particular,
functional disorders in the receptors such as nerotrophic
receptors (TrkB) [49], ion channels [50], NMDA receptor
[51], and muscarinic acetylcholine receptors [52] should
be considered. Activation of proteases such as calpain
might also be involved as reported [53]. We are now
conducting trials to identify those factors.
Recently, it has been reported that the complement
system may play beneficial roles in the development and
maintenance of the nervous systems [54,55]. Genetic
inactivation of the complement system resulted in the
various abnormal features in the nervous systems; for
example, failure of anatomical refinement of retinogen-
iculate connections and the retention of excess retinal
innervation by lateral geniculate neurons were observedin C1q-deficient mice [54]. Reduced clearance of fibrillar
amyloid-beta by microglia was found in C3 and Mac-1
KO mice [56]. Furthermore, complement receptor 2−/−
mice exhibited prominent increases in basal neurogenesis
[57]. In our results, C3-deficient mutant mice showed
slightly higher neuron numbers in spinal lamina II, sug-
gesting that sufficient clearance of deteriorating neuronal
tissues might not be achieved during the development in
C3-deficient mice.
As previously described, the complement system plays
important roles in both neuroprotection and neurode-
generation [25] and seems to be a dual-edged sword [18].
The fact that TKO mice lacking a complement system
showed apparently improved histology in the spinal cord
compared with DKO mice suggests that influences of
complement deficiency in the development of mice
were not so serious as neuroinflammation and neuro-
degeneration, which exacerbated with aging (that is, in
the maintenance of nerve tissues after birth). Mechanisms
for complement activation due to ganglioside deficiency in
the spinal cord remain to be clarified.
Disruption in the architecture of lipid rafts in the
spinal cord was not so prominent as in brain tissues,
suggesting that mechanisms distinct from those reported
might be involved in the complement activation in the
spinal cord of DKO mice. Gene expression profiling re-
vealed that inflammation and neurodegeneration in the
spinal cord of DKO mice are dependent, at least partly,
on complement activation due to ganglioside deficiency.Additional file
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